Home > Insider Trading > Filing (0001415889-23-011450)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1646649	Jonathan Sheena	C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-07-20	190	$0.00	509,936	No	4	M	Direct
Common Stock	Acquisiton	2023-07-21	143	$0.00	510,079	No	4	M	Direct
Common Stock	Disposition	2023-07-21	233	$47.56	509,846	No	4	S	Direct
Common Stock	Disposition	2023-07-21	500	$47.56	24,155	No	4	S	Indirect	By Caraluna Trust 1
Common Stock	Disposition	2023-07-21	500	$47.56	24,155	No	4	S	Indirect	By Caraluna Trust 2
Common Stock	Disposition	2023-07-24	100	$47.82	509,746	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	By Caraluna Trust 1
No	4	S	Indirect	By Caraluna Trust 2
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2023-07-20	190	$0.00	190	$0.00
Common Stock	Restricted Stock Unit	Disposition	2023-07-21	143	$0.00	143	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,903			No	4	M	Direct
859			No	4	M	Direct

Footnotes

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.
Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.24 to $47.8365 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.
The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter